Evotec Appoints Dr Ingrid Müller as Chief Operating Officer
Evotec has announced the appointment of Dr Ingrid Müller as Chief Operating Officer (COO). Dr Müller will be joining Evotec’s Management Board, effective 1...
Renaissance Pharma secures FDA Fast Track Designation and IND clearance for...
The US Food and Drug Administration (FDA) has granted Fast Track Designation for Daretabart (hu1418K322A), a novel anti-GD2 monoclonal antibody in development for the...
AbbVie’s Elahere succeeds in phase 2 platinum-sensitive ovarian cancer trial
AbbVie has announced that late-breaking results from the phase 2 IMGN853-0420 trial.
The study evaluated the potential efficacy and safety of mirvetuximab soravtansine-gynx, a first-in-class antibody-drug...
